Current Pharmacological Treatment Approaches to Central Nervous System Leukaemia (Q36663798)

15 August 2017

1 reference

title

Current pharmacological treatment approaches to central nervous system leukaemia (English)

1 reference

15 August 2017

Current Pharmacological Treatment Approaches to Central Nervous System Leukaemia (English)

1 reference

10.2165/00003495-199141050-00003

Crossref

DOI

https://api.crossref.org/works/10.2165/00003495-199141050-00003

5 November 2022

1 reference

2

F. M. Balis

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1712705

5 November 2022

author name string

S. M. Blaney

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1712705

5 November 2022

D. G. Poplack

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1712705

5 November 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1712705

5 November 2022

publication date

1 May 1991

1 reference

15 August 2017

1 reference

15 August 2017

41

1 reference

15 August 2017

5

1 reference

15 August 2017

702-716

1 reference

https://scigraph.springernature.com/pub.10.2165/00003495-199141050-00003

15 August 2017

0 references

cites work

Phase II and pharmacokinetic study of aziridinylbenzoquinone [2,5-diaziridinyl-3,6-bis(carboethoxyamino)-1,4-benzoquinone, diaziquone, NSC 182986] in high-grade gliomas.

1 reference

12 December 2020

Remission induction of meningeal leukemia with high-dose intravenous methotrexate

1 reference

12 December 2020

Intermediate-dose intravenous methotrexate and mercaptopurine therapy for non-T, non-B acute lymphocytic leukemia of childhood: a Pediatric Oncology Group study

1 reference

12 December 2020

Central nervous system pharmacology of antileukemic drugs

1 reference

12 December 2020

The increasing incidence of central nervous system leukemia in children. (Children's Cancer Study Group A).

1 reference

12 December 2020

Pharmacology and toxicity of high-dose cytarabine by 72-hour continuous infusion

1 reference

12 December 2020

Central nervous system toxicity of high-dose cytosine arabinoside

1 reference

12 December 2020

Central nervous system pharmacokinetics of high-dose cytosine arabinoside.

1 reference

12 December 2020

The central nervous system in childhood leukemia: I. The arachnoid

1 reference

12 December 2020

The influence of previous lumbar puncture and pneumoencephalography on the incidence of unsuccessful radioisotope cisternography

1 reference

12 December 2020

Physicochemical considerations and pharmacokinetic behavior in delivery of drugs to the central nervous system.

1 reference

12 December 2020

Multivesicular liposomes containing 1-beta-D-arabinofuranosylcytosine for slow-release intrathecal therapy

1 reference

12 December 2020

Prophylaxis and treatment of leukemia in the central nervous system and other sanctuaries

1 reference

12 December 2020

Leukoencephalopathy following the administration of methotrexate into the cerebrospinal fluid in the treatment of primary brain tumors

1 reference

12 December 2020

Central nervous system therapy and combination chemotherapy of childhood lymphocytic leukemia

1 reference

12 December 2020

Studies of the enzymatic deamination of cytosine arabinoside. I. Enzyme distribution and species specificity

1 reference

12 December 2020

Cerebrospinal fluid flow abnormalities in patients with neoplastic meningitis. An evaluation using 111indium-DTPA ventriculography

1 reference

12 December 2020

Neurotoxicity and Elevated Cerebrospinal-Fluid Methotrexate Concentration in Meningeal Leukemia

1 reference

12 December 2020

Differences in cerebrospinal fluid penetration of corticosteroids: possible relationship to the prevention of meningeal leukemia

1 reference

12 December 2020

Central nervous system toxicity with high-dose cytosine arabinoside

1 reference

12 December 2020

Methotrexate: distribution in cerebrospinal fluid after intravenous, ventricular and lumbar injections

1 reference

12 December 2020

Paraplegia following intrathecal cytosine arabinoside

1 reference

12 December 2020

Seizures following intrathecal cytosine arabinoside in young children with acute lymphoblastic leukemia

1 reference

12 December 2020

High dose systemic methotrexate-associated acute neurologic dysfunction

1 reference

12 December 2020

Reduction in central nervous system leukemia with a pharmacokinetically derived intrathecal methotrexate dosage regimen

1 reference

12 December 2020

Cytosine arabinoside cerebrospinal fluid kinetics

1 reference

12 December 2020

Clinical pharmacology of l-β-D-arabinofuranosyl cytosine

1 reference

12 December 2020

Encephalopathy in acute leukaemia associated with methotrexate therapy

1 reference

12 December 2020

Comparison of three methods of central-nervous-system prophylaxis in childhood acute lymphoblastic leukaemia

1 reference

12 December 2020

Primate Model for Long-Term Study of Intraventricularly or Intrathecally Administered Drugs and Intracranial Pressure

1 reference

12 December 2020

1 reference

12 December 2020

Clinical investigations in the treatment of meningeal leukemia: radiation therapy regimens vs. conventional intrathecal methotrexate

1 reference

12 December 2020

Neurotoxicity of antineoplastic drugs

1 reference

12 December 2020

Neurologic sequelae of methotrexate and ionizing radiation: a new classification

1 reference

12 December 2020

The central nervous system in childhood leukemia.II. Subacute leukoencephalopathy

1 reference

12 December 2020

Intrathecal chemotherapy: brain tissue profiles after ventriculocisternal perfusion

1 reference

12 December 2020

Pharmacokinetics of intraventricular and intravenous N,N',N''-triethylenethiophosphoramide (thiotepa) in rhesus monkeys and humans.

1 reference

12 December 2020

Irradiation, methotrexate toxicity, and the treatment of meningeal leukaemia

1 reference

12 December 2020

L-asparaginase pharmacokinetics and asparagine levels in cerebrospinal fluid of rhesus monkeys and humans

1 reference

12 December 2020

A phase II study of diaziquone in children with recurrent or progressive solid tumors. Report from the Childrens Cancer Study Group

1 reference

12 December 2020

Phase I and clinical pharmacological study of mercaptopurine administered as a prolonged intravenous infusion

1 reference

12 December 2020

Clinical pharmacology of intrathecal methotrexate. II. An improved dosage regimen derived from age-related pharmacokinetics

1 reference

12 December 2020

High-dose cytosine arabinoside therapy for refractory leukemia

1 reference

12 December 2020

Intraventricular versus intralumbar methotrexate for central-nervous-system leukemia: Prolonged remission with the ommaya reservoir

1 reference

12 December 2020

Successful treatment of meningeal leukemia using systemic high-dose cytosine arabinoside

1 reference

12 December 2020

"Concentration x time" methotrexate via a subcutaneous reservoir: a less toxic regimen for intraventricular chemotherapy of central nervous system neoplasms

1 reference

12 December 2020

The cytosine arabinoside (Ara-C) syndrome

1 reference

12 December 2020

The pharmacokinetics of cytosine arabinoside in the plasma and cerebrospinal fluid during conventional and high-dose therapy

1 reference

12 December 2020

Binding of drugs to serum albumin (first of two parts)

1 reference

12 December 2020

Cerebrospinal fluid pharmacokinetics of intraventricular and intravenous aziridinylbenzoquinone

1 reference

12 December 2020

10.2165/00003495-199141050-00003

Identifiers

DOI

1 reference

Dimensions Publication ID

15 August 2017

0 references

1 reference